Inve India ▾

Transpek Industry share price & results

Transpek Industry Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Vadodara-based manufacturer of chlorinated and sulphur-based specialty chemicals (acid chlorides, alkyl chlorides) supplying pharma, agrochemical, polymer, dye and cosmetics industries worldwide.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue151 ₹ crore−2.1% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin13.3 %−2.3 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit8.9 ₹ crore−42.7% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity5.15 %−1.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin6.60 %−11.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-5.24 %−16.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

0 of 5 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Transpek Industry Limited management guidance track record on Inve: 15 targets tracked across analysed earnings calls (0 achieved, 5 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
New Products EBITDA Margins20%
Call transcript, Q3 FY25 · 21 Feb 2025		Q3 FY25Q1 FY27:No specific update on new product margins. Management provided overall company EBITDA margin guidance of 15-20%.
Call transcript, Q1 FY27 · 20 Aug 2026		Ghosted
New Products Revenue (Non-Acid Chloride)₹150-200 crores annually within 2 years
Call transcript, Q3 FY25 · 21 Feb 2025		Q3 FY25Q1 FY27:Timelines for new polymer products (potential ₹100cr) have been pushed out, with one starting revenue in Q4 FY27 and another in FY28, missing the original 2-year deadline (end of Q3 FY27).
Call transcript, Q1 FY27 · 20 Aug 2026		Delayed
DuPont Contract VolumeSustain current supply volumes until current contract ends
Call transcript, Q3 FY25 · 21 Feb 2025		Q3 FY25Q1 FY27:Management confirmed the contract, now with Arclin, continues without disruption. Renewal discussions are set to begin in late 2026.
Call transcript, Q1 FY27 · 20 Aug 2026		On Track

Source: Inve Guidance Tracker for Transpek Industry Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

5 of Transpek Industry Limited's 15 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 12 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,283.9 +0.54% · +₹6.9

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −6.7% 1Y

₹1.0k₹1.2k₹1.4kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q1 FY27 — 20 Aug 2026

1Y: ₹1,376.2 on 24 Oct 2025 → ₹1,283.9. High ₹1,446.5 (4 Sept 2026), low ₹876.3 (30 Mar 2026).

Previous close
₹1,277
Market cap
₹720 Cr
52-week range
₹876.3 – ₹1,446.5
One year
−5.26%
Price to earnings (TTM to Jun 2026)
18.46×
Return on equity (TTM to Jun 2026)
5.15%

Overview

Symbol
NSE:TRANSPEK
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Transpek Industry Limited does

Based on the company's own presentations, annual report and earnings calls.

Transpek Industry Limited manufactures chlorinated and sulphur-based specialty chemicals, including Thionyl Chloride and a range of acid chlorides and alkyl chlorides, used as intermediates for pharmaceuticals, agrochemicals, dyes, polymers, cosmetics and surfactants. It operates multipurpose, multiproduct manufacturing plants at Ekalbara near Vadodara, Gujarat, supported by an in-house R&D facility for developing new chlorination-based chemistries. The company exports to customers across roughly 16 countries including the US, Europe and Japan, moving bulk chemicals through its own managed fleet of ISO tank containers. It is part of the Excel Industries group of companies.

Segments

  • Polymers
  • Pharma
  • Specialty Chemicals
  • Agrochemicals
  • Cosmetics
  • Dyes
  • Surfactants
Installed production capacity
66,000 MTPA
Manufacturing facility
Multipurpose, multiproduct plants at Ekalbara (Vadodara, Gujarat), spread over 100 acres
Export footprint
Presence across 16 countries
Capacity utilization
~65% (Q3 FY25)
ISO tank logistics fleet
600+ ISO tanks with own repair and cleaning stations
Operating history
50+ years of experience in chlorine and sulphur chemistry
Founded 1965Headquarters Vadodara, Gujarat, India Company website

How the price took the results

close before → close after

Q1 FY27
+4.6%
20 Aug

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Transpek Industry Limited

Free account: one company. Everything above stays public.

Write why you follow Transpek Industry Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Transpek Industry Limited

Guides on how to read this kind of business and the numbers that matter.